Cargando…
Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris;...
Autores principales: | Garcia-Jeldes, Hector Felipe, Mitchell, Robyn, McGeer, Allison, Rudnick, Wallis, Amaratunga, Kanchana, Vallabhaneni, Snigdha, Lockhart, Shawn R., Bharat, Amrita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288437/ https://www.ncbi.nlm.nih.gov/pubmed/32522237 http://dx.doi.org/10.1186/s13756-020-00752-3 |
Ejemplares similares
-
2166. Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) Hospitals, 2018
por: Jeldes, Felipe Garcia, et al.
Publicado: (2018) -
On the Origins of a Species: What Might Explain the Rise of Candida auris?
por: Jackson, Brendan R., et al.
Publicado: (2019) -
1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility
por: Paul, Prabasaj, et al.
Publicado: (2018) -
Notes from the Field: Surveillance for
Candida auris — Colombia, September 2016–May
2017
por: Escandón, Patricia, et al.
Publicado: (2018) -
Candida auris in a U.S. Patient with Carbapenemase-Producing Organisms and Recent Hospitalization in Kenya
por: Brooks, Richard B., et al.
Publicado: (2019)